AlzChem Group AG (ACT0) AI Stock Analysis

56 Followers

AlzChem Group AG

(XETRA:ACT0)

Select Model

Rating:66Neutral

Price Target:EUR 167.00▲(18.27% Upside)

Action:reiterated

Date:11/05/26

The score is driven primarily by strong underlying profitability/growth and constructive (reaffirmed) guidance with Specialty Chemicals momentum. This is tempered by weaker technicals (price below key moving averages with negative MACD) and cash-flow quality concerns (low/volatile free cash flow and rising debt), while valuation appears only moderate given a ~23.85 P/E and ~1.5% dividend yield.

Positive Factors

Specialty Chemicals growthThe Specialty Chemicals segment is becoming a larger and more profitable earnings engine, supported by volume growth, favorable mix, high utilization, and differentiated applications. Its rising sales contribution and near-30% margin can improve group earnings quality over the next several quarters.

Negative Factors

Agriculture demand weaknessAgriculture and fertilizer exposure remains vulnerable to weak customer economics and persistent import competition. Delayed fertilization can suppress volumes, while cost disadvantages may limit pricing power and keep this part of the portfolio from contributing fully to group growth.

AlzChem Group AG (ACT0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.46B
Dividend Yield: 1.50%
Average Volume (3M): 18.47K
Price to Earnings (P/E): 23.9
Beta (1Y): 0.53
Revenue Growth: ―
EPS Growth: ―
Country: Germany
Employees: 1,765
Sector: Basic Materials
Sector Strength: 61
Industry: Chemicals

AlzChem Group AG Business Overview & Revenue Model

Company Description

Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. It operates through the following segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment fo...

How the Company Makes Money

AlzChem makes money by manufacturing and selling chemical products and specialty formulations to business customers, generating revenue primarily from (1) higher-margin specialty products and (2) larger-volume basic/industrial chemical products. Key...

AlzChem Group AG Financial Statement Overview

Summary

Fundamentals are solid: strong TTM revenue growth and healthy profitability (~20% EBITDA margin, ~12% net margin) with attractive ROE and moderate leverage (debt-to-equity ~0.33). Offsetting this, margin volatility and weaker free cash flow conversion (TTM FCF ~€19m with a sharp decline vs. prior year) plus rising debt reduce quality/consistency versus headline earnings.

Income Statement

78Positive

Balance Sheet

74Positive

Cash Flow

61Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	578.46M	562.12M	554.23M	540.65M	542.22M	422.29M
Gross Profit	82.27M	177.59M	163.08M	304.07M	282.72M	268.34M
EBITDA	116.51M	109.44M	103.96M	81.75M	68.06M	61.89M
Net Income	67.77M	63.46M	54.08M	34.62M	30.05M	27.59M
Balance Sheet
Total Assets	674.11M	617.68M	483.83M	424.68M	422.86M	377.67M
Cash, Cash Equivalents and Short-Term Investments	65.69M	78.20M	63.15M	13.92M	9.62M	8.73M
Total Debt	90.22M	44.23M	52.82M	62.49M	100.23M	55.64M
Total Liabilities	402.19M	359.45M	276.36M	261.12M	276.91M	288.10M
Stockholders Equity	269.90M	256.30M	205.54M	161.63M	144.01M	87.63M
Cash Flow
Free Cash Flow	18.69M	39.22M	62.05M	52.11M	-33.31M	14.48M
Operating Cash Flow	116.48M	137.01M	105.15M	72.67M	-4.24M	43.02M
Investing Cash Flow	-137.63M	-96.90M	-30.99M	-20.55M	-28.51M	-28.48M
Financing Cash Flow	22.42M	-29.36M	-24.66M	-49.17M	33.65M	-23.62M

AlzChem Group AG Technical Analysis

Technical Analysis SentimentNegative

Last Price141.20

Price Trends

50DMA160.79Negative

100DMA164.94Negative

200DMA165.06Negative

Market Momentum

MACD-3.78Positive

RSI29.91Positive

STOCH16.89Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:ACT0, the sentiment is Negative. The current price of 141.20 is below the 20-day moving average (MA) of 158.63, below the 50-day MA of 160.79, and below the 200-day MA of 165.06, indicating a bearish trend. The MACD of -3.78 indicates Positive momentum. The RSI at 29.91 is Positive, neither overbought nor oversold. The STOCH value of 16.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:ACT0.

AlzChem Group AG Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

DE:ACT0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:FPE	69Neutral	EUR 5.30B	15.77	17.37%	3.29%	12.08%	21.84%
DE:ACT0	66Neutral	EUR 1.40B	23.85	26.12%	1.50%	―	―
DE:EVK	64Neutral	EUR 9.66B	81.28	1.49%	4.76%	1.98%	83.13%
DE:BNR	62Neutral	EUR 9.15B	24.85	8.30%	3.03%	-5.28%	-13.76%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
DE:WCH	53Neutral	EUR 4.17B	-9.26	-11.14%	2.98%	―	―
DE:LXS	38Underperform	EUR 1.03B	-1.53	-18.62%	0.84%	-9.81%	-305.46%

* Basic Materials Sector Average

Performance Comparison

DE:ACT0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:ACT0	AlzChem Group AG	141.20	1.22	0.87%
DE:BNR	Brenntag AG (UK)	62.62	17.82	39.76%
DE:EVK	Evonik Industries AG	21.02	7.95	60.80%
DE:FPE	Fuchs Petrolub	37.05	7.84	26.86%
DE:LXS	Lanxess (OTC)	11.87	-5.07	-29.94%
DE:WCH	Wacker Chemie Ag (OTC)	81.80	14.55	21.64%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 04, 2026

AlzChem Group AG AI Stock Analysis